Comtan (entacapone) / Orion Corp, Alvogen, Novartis  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Comtan (entacapone) / Novartis, Orion Corp
NCT00199394 / 2004-000817-20: A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease

Completed
3
405
Europe
Istradefylline (KW-6002)
Kyowa Kirin Co., Ltd., Kyowa Hakko Kirin UK, Ltd.
Parkinson's Disease
10/05
11/05
NCT00360308 / 2006-002937-20: Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

Terminated
3
723
Europe
Placebo, E2007
Eisai Limited
Parkinson's Disease
04/08
04/08
BIPARK-I, NCT01568073 / 2010-021860-13: Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon

Completed
3
600
Europe
BIA 9-1067, OPC, Opicapone, Entacapone, Comtan®, Placebo, PLC, Levodopa, L-Dopa, Carbidopa, Benserazide
Bial - Portela C S.A.
Parkinson's Disease
11/13
11/13

Download Options